June 2008. Volume 4. Number 2

New tetravalent meningococcal vaccine in children. A step forward?

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Snape MD, Perret KP, Ford KJ, John TM, Pace D, Yu L-M, et al. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants. A randomized controlled trial. JAMA. 2008;299:173-84
Reviewers: Juanes de Toledo B1, Ruiz-Canela Cáceres J2.
1 Equipo de Atención Primaria El Espinillo. Área-11. Madrid. España.
2 Distrito Sanitario Sevilla. España.
Correspondence: Blanca Juanes de Toledo. Email: blancajuanes@telefonica.net
Reception date: 02/05/2008
Acceptance date: 07/05/2008
Publication date: 01/06/2008

Abstract

How to cite this article

Juanes de Toledo B.,Ruiz-Canela Caceres J. Nueva vacuna antimeningocócica tetravalente en niños. ¿Un paso más? Evid Pediatr. 2008;4:33

AVC | Critically appraised articles

Snape MD, Perret KP, Ford KJ, John TM, Pace D, Yu L-M, et al. Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants. A randomized controlled trial. JAMA. 2008;299:173-84
Reviewers: Juanes de Toledo B1, Ruiz-Canela Cáceres J2.
1 Equipo de Atención Primaria El Espinillo. Área-11. Madrid. España.
2 Distrito Sanitario Sevilla. España.
Correspondence: Blanca Juanes de Toledo. Email: blancajuanes@telefonica.net
Reception date: 02/05/2008
Acceptance date: 07/05/2008
Publication date: 01/06/2008

How to cite this article

Juanes de Toledo B.,Ruiz-Canela Caceres J. Nueva vacuna antimeningocócica tetravalente en niños. ¿Un paso más? Evid Pediatr. 2008;4:33

References

  1. CDC. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2005;54(No. RR-7). [en línea] [fecha de consulta: 2-5-2008 ]. URL disponible en: http://www.cdc.gov/MMWR/PREVIEW/MMWRHTML/rr5407a1.htm
  2. Food and Drug Administration. Product approval information-licensing action, package insert: Meningococcal (groups A, C, Y, W-135) polysaccharide diphtheria toxoid conjugate vaccine Menactra®. Rockville, MD: US Department of Health and Human Services, Food and Drug Administration; 2005. [en línea] [fecha de consulta: 2-5-2008 ]. URL disponible en: http://www.fda.gov/cber/label/menactralb.pdf
  3. Pichichero M, Casey J, Blatter M, Rothstein E, Ryall R, Bybel M, et al. Comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two- to ten-year-old children. Pediatr Infect Dis J. 2005;24:57-62.
  4. CDC. Report from the Advisory Committee on Immunization Practices (ACIP): Decision Not to Recommend Routine Vaccination of All Children Aged 2--10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4). [en línea][fecha de consulta: 2-5-2008 ]. URL disponible en: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5717a4.htm?s_cid=mm5717a4_e#top
  5. Cano Portero R. Enfermedad meningocócica en España. Análisis de la temporada 2005-2006. Centro Nacional de Epidemiologia Instituto Carlos III . [en línea] [fecha de consulta: 2-5-2008 ]. URL disponible en: http://www.isciii.es/htdocs/centros/epidemiologia/boletin_semanal/bes0729.pdf
01/06/2008

Linked Comment